PDCD1 and non-small cell lung carcinoma: Using two independent cohorts of, respectively, advanced NSCLC patients treated with anti-PD1/anti-PDL1 drugs, the analysis by Conforti et al. suggested that TMB could have a solid and linear association with both PFS and OS only in women and that considering different TMB cutoff points in both genders may improve its predictive value for both.